Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mind Medicine (MindMed) Inc. - Common Shares
(NQ:
MNMD
)
7.630
-0.550 (-6.72%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,237,912
Open
8.370
Bid (Size)
7.600 (9)
Ask (Size)
7.700 (25)
Prev. Close
8.180
Today's Range
7.625 - 8.500
52wk Range
4.660 - 12.22
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
February 20, 2025
From
Mind Medicine Inc.
Via
Business Wire
New Study Shows Ibogaine Can Be Made Without Using Plant Matter
February 18, 2025
Via
Investor Brand Network
Performance
YTD
+1.19%
+1.19%
1 Month
+6.12%
+6.12%
3 Month
+0.26%
+0.26%
6 Month
+24.67%
+24.67%
1 Year
+55.40%
+55.40%
More News
Read More
Why Mind Medicine Stock Is Skyrocketing Today
February 14, 2025
Via
The Motley Fool
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months
February 14, 2025
Via
Stocktwits
RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care.
February 12, 2025
Via
Investor's Business Daily
Why Mind Medicine Stock Is Soaring Today
January 07, 2025
Via
The Motley Fool
MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 04, 2025
From
Mind Medicine Inc.
Via
Business Wire
MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder
January 30, 2025
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish
January 28, 2025
Via
Stocktwits
This Westlake Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
January 28, 2025
Via
Benzinga
MindMed to Be Added to the Nasdaq Biotechnology Index
December 19, 2024
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD)
December 16, 2024
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress
December 11, 2024
From
Mind Medicine
Via
Business Wire
MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)
December 05, 2024
From
Mind Medicine Inc.
Via
Business Wire
MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy
December 03, 2024
From
Mind Medicine Inc.
Via
Business Wire
MindMed Announces New Employee Inducement Grants
December 02, 2024
From
Mind Medicine Inc.
Via
Business Wire
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
November 29, 2024
Via
The Motley Fool
MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer
November 18, 2024
From
Mind Medicine (MindMed) Inc.
Via
Business Wire
AI And Psychedelics: A Marriage Made In Heaven For Mental Health Care?
November 13, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
MindMed to Participate in Upcoming Investor Conferences
November 13, 2024
From
Mind Medicine Inc.
Via
Business Wire
MindMed Reports Third Quarter 2024 Financial Results and Business Updates
November 07, 2024
From
Mind Medicine Inc.
Via
Business Wire
MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update
October 24, 2024
From
Mind Medicine Inc.
Via
Business Wire
Psychedelic Drug Stocks +6% Last Week Vs. -13% Previous Week
September 15, 2024
Via
Talk Markets
Psychedelic Compound-Based Drug Stocks Portfolio -13% W/e Sept. 6th
September 10, 2024
Via
Talk Markets
MindMed Announces New Employee Inducement Grants
September 09, 2024
From
Mind Medicine Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.